Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 44, pseudogene (RNU6-44P)
- Target
- RNU6-44P
- Molecular classification
- Other, Pseudogene (noncoding RNA pseudogene)
01
Overview
RNU6-44P is a **pseudogene** belonging to the *U6 small nuclear RNA* (snRNA) family. U6 snRNAs are highly conserved uridine-rich noncoding RNAs that form an essential component of the spliceosome, participating in pre-mRNA splicing within eukaryotic nuclei[1][3]. Unlike active U6 snRNA genes, **RNU6-44P** does **not** produce a functional RNA and is annotated as a **pseudogene**, likely resulting from retrotransposition events involving LINE-1 (L1) elements[5]. Such U6 snRNA pseudogenes are scattered throughout the genome and serve as historical markers of retrotransposition, rather than playing roles in cell biology or disease mechanisms[3][5]. RNU6-44P is located on chromosome 11 (chr11:112,352,556-112,352,662, hg38)[2]. There is no evidence that this pseudogene has any direct clinical, diagnostic, or therapeutic relevance.
- Other names
- RNU6-44PRNU6-44RNA, U6 small nuclear 44, pseudogene
02
Mechanism of action
None (not targeted by drugs)
03
Biological functions
None (as a pseudogene, it does not have a known biological function; functional U6 snRNA is involved in RNA splicing, but pseudogenes generally lack function)
04
Disease associations
Other (U6 snRNA pseudogenes are considered markers of retrotransposition activity and genome evolution, but are not directly implicated in specific diseases)
Beyond the preview
Go deeper on RNA, U6 small nuclear 44, pseudogene (RNU6-44P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 44, pseudogene (RNU6-44P).